user: GUEST
width: 600



DescriptionRecName: Full=Peflin {ECO:0000303|PubMed:10486255}; AltName: Full=PEF protein with a long N-terminal hydrophobic domain {ECO:0000303|PubMed:10486255}; AltName: Full=Penta-EF hand domain-containing protein 1 {ECO:0000312|HGNC:HGNC:30009};
MyHits logo
MyHits synonymsPEF1_HUMAN , Q9UBV8 , 2E9AA5750CB7A68A
match map segment
ismart:EFh ipfam:EF-hand_6 ipat:EF_HAND_1 ipat:EF_HAND_1 iprf:EF_HAND_2 ismart:EFh ismart:EFh ipfam:EF-hand_7 iprf:EF_HAND_2  
Legends: 1, CROSSLNK Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin). {ECO:0000305|PubMed:27716508}; 2, MUTAGEN K->R: Decreased ubiquitination by the BCR(KLHL12) E3 ubiquitin ligase complex. {ECO:0000269|PubMed:27716508}; 3, MUTAGEN K->R: Does not affect ubiquitination by the BCR(KLHL12) E3 ubiquitin ligase complex. {ECO:0000269|PubMed:27716508}; 4, REPEAT 1. {ECO:0000305}; 5, REPEAT 2. {ECO:0000305}; 6, REPEAT 3. {ECO:0000305}; 7, REPEAT 4. {ECO:0000305}; 8, REPEAT 5. {ECO:0000305}; 9, REPEAT 6. {ECO:0000305}; 10, REPEAT 7. {ECO:0000305}; 11, REPEAT 8. {ECO:0000305}; 12, REPEAT 9. {ECO:0000305}; 13, EF-hand 1. {ECO:0000255|PROSITE- ProRule:PRU00448}; 14, EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}; 15, EF-hand 3. {ECO:0000255|PROSITE- ProRule:PRU00448}; 16, EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}; 17, EF-hand 5. {ECO:0000255|PROSITE- ProRule:PRU00448}; 18, CA_BIND 1. {ECO:0000255|PROSITE- ProRule:PRU00448}; 19, CA_BIND 2. {ECO:0000255|PROSITE- ProRule:PRU00448}; 20, REGION 9 X 9 AA approximate tandem repeat of [AP]-P-G-G-P-Y-G-G-P-P. {ECO:0000305}; 21, REGION Required for interaction with PDCD6. {ECO:0000269|PubMed:11883899}; 22, ismart:EFh [T]; 23, ipfam:EF-hand_6 [T]; 24, ipat:EF_HAND_1 [T]; 25, iprf:EF_HAND_2 [T].
ID   PEF1_HUMAN              Reviewed;         284 AA.
AC   Q9UBV8;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Peflin {ECO:0000303|PubMed:10486255};
DE   AltName: Full=PEF protein with a long N-terminal hydrophobic domain {ECO:0000303|PubMed:10486255};
DE   AltName: Full=Penta-EF hand domain-containing protein 1 {ECO:0000312|HGNC:HGNC:30009};
GN   Name=PEF1 {ECO:0000312|HGNC:HGNC:30009}; Synonyms=ABP32;
GN   ORFNames=UNQ1845/PRO3573 {ECO:0000303|PubMed:12975309};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10486255; DOI=10.1006/bbrc.1999.1189;
RA   Kitaura Y., Watanabe M., Satoh H., Kawai T., Hitomi K., Maki M.;
RT   "Peflin, a novel member of the five-EF-hand-protein family, is similar
RT   to the apoptosis-linked gene 2 (ALG-2) protein but possesses
RT   nonapeptide repeats in the N-terminal hydrophobic region.";
RL   Biochem. Biophys. Res. Commun. 263:68-75(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RA   Shibata M., Noguchi J.;
RT   "A putative calcium binding protein that has five EF-hand motifs.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PDCD6.
RX   PubMed=11278427; DOI=10.1074/jbc.M008649200;
RA   Kitaura Y., Matsumoto S., Satoh H., Hitomi K., Maki M.;
RT   "Peflin and ALG-2, members of the penta-EF-hand protein family, form a
RT   heterodimer that dissociates in a Ca2+-dependent manner.";
RL   J. Biol. Chem. 276:14053-14058(2001).
RN   [8]
RP   INTERACTION WITH PDCD6.
RX   PubMed=11883899; DOI=10.1006/abbi.2001.2736;
RA   Kitaura Y., Satoh H., Takahashi H., Shibata H., Maki M.;
RT   "Both ALG-2 and peflin, penta-EF-hand (PEF) proteins, are stabilized
RT   by dimerization through their fifth EF-hand regions.";
RL   Arch. Biochem. Biophys. 399:12-18(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PDCD6, UBIQUITINATION
RP   AT LYS-137, AND MUTAGENESIS OF LYS-137; LYS-165 AND LYS-167.
RX   PubMed=27716508; DOI=10.1016/j.cell.2016.09.026;
RA   McGourty C.A., Akopian D., Walsh C., Gorur A., Werner A., Schekman R.,
RA   Bautista D., Rape M.;
RT   "Regulation of the CUL3 ubiquitin ligase by a calcium-dependent co-
RT   adaptor.";
RL   Cell 167:525-538(2016).
CC   -!- FUNCTION: Calcium-binding protein that acts as an adapter that
CC       bridges unrelated proteins or stabilizes weak protein-protein
CC       complexes in response to calcium. Together with PDCD6, acts as
CC       calcium-dependent adapter for the BCR(KLHL12) complex, a complex
CC       involved in endoplasmic reticulum (ER)-Golgi transport by
CC       regulating the size of COPII coats (PubMed:27716508). In response
CC       to cytosolic calcium increase, the heterodimer formed with PDCD6
CC       interacts with, and bridges together the BCR(KLHL12) complex and
CC       SEC31 (SEC31A or SEC31B), promoting monoubiquitination of SEC31
CC       and subsequent collagen export, which is required for neural crest
CC       specification (PubMed:27716508). Its role in the heterodimer
CC       formed with PDCD6 is however unclear: some evidences show that
CC       PEF1 and PDCD6 work together and promote association between PDCD6
CC       and SEC31 in presence of calcium (PubMed:27716508). Other reports
CC       show that PEF1 dissociates from PDCD6 in presence of calcium, and
CC       may act as a negative regulator of PDCD6 (PubMed:11278427). Also
CC       acts as a negative regulator of ER-Golgi transport; possibly by
CC       inhibiting interaction between PDCD6 and SEC31 (By similarity).
CC       {ECO:0000250|UniProtKB:Q641Z8, ECO:0000269|PubMed:11278427,
CC       ECO:0000269|PubMed:27716508}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes (via the EF-hand 5) with
CC       PDCD6 (PubMed:11278427, PubMed:11883899, PubMed:27716508).
CC       Dissociates from PDCD6 in presence of calcium (PubMed:11278427).
CC       {ECO:0000269|PubMed:11278427, ECO:0000269|PubMed:11883899,
CC       ECO:0000269|PubMed:27716508}.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=4; IntAct=EBI-724639, EBI-739580;
CC       D3DR37:CEP55; NbExp=3; IntAct=EBI-724639, EBI-10173536;
CC       Q15038:DAZAP2; NbExp=5; IntAct=EBI-724639, EBI-724310;
CC       Q01844:EWSR1; NbExp=3; IntAct=EBI-724639, EBI-739737;
CC       Q6PJQ5:FOXR2; NbExp=5; IntAct=EBI-724639, EBI-8468543;
CC       O14964:HGS; NbExp=3; IntAct=EBI-724639, EBI-740220;
CC       Q53G59:KLHL12; NbExp=7; IntAct=EBI-724639, EBI-740929;
CC       O75340:PDCD6; NbExp=11; IntAct=EBI-724639, EBI-352915;
CC       Q5JUK2:SOHLH1; NbExp=4; IntAct=EBI-724639, EBI-12288855;
CC       Q92734:TFG; NbExp=5; IntAct=EBI-724639, EBI-357061;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11278427}.
CC       Endoplasmic reticulum {ECO:0000250|UniProtKB:Q641Z8}. Membrane
CC       {ECO:0000269|PubMed:11278427}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11278427}. Cytoplasmic vesicle, COPII-coated
CC       vesicle membrane {ECO:0000269|PubMed:27716508}; Peripheral
CC       membrane protein {ECO:0000305}. Note=Membrane-associated in the
CC       presence of Ca(2+) (PubMed:11278427). Localizes to endoplasmic
CC       reticulum exit site (ERES) (By similarity).
CC       {ECO:0000250|UniProtKB:Q641Z8, ECO:0000269|PubMed:11278427}.
CC   -!- PTM: Ubiquitinated by the BCR(KLHL12) E3 ubiquitin ligase complex.
CC       {ECO:0000269|PubMed:27716508}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB026628; BAA85163.1; -; mRNA.
DR   EMBL; AB018357; BAA84922.1; -; mRNA.
DR   EMBL; AY359011; AAQ89370.1; -; mRNA.
DR   EMBL; AK001420; BAA91680.1; -; mRNA.
DR   EMBL; CR542139; CAG46936.1; -; mRNA.
DR   EMBL; BC002773; AAH02773.1; -; mRNA.
DR   EMBL; BC012561; AAH12561.1; -; mRNA.
DR   CCDS; CCDS345.1; -.
DR   RefSeq; NP_036524.1; NM_012392.3.
DR   UniGene; Hs.470417; -.
DR   ProteinModelPortal; Q9UBV8; -.
DR   SMR; Q9UBV8; -.
DR   BioGrid; 139275; 28.
DR   IntAct; Q9UBV8; 49.
DR   MINT; MINT-5003645; -.
DR   STRING; 9606.ENSP00000362807; -.
DR   iPTMnet; Q9UBV8; -.
DR   PhosphoSitePlus; Q9UBV8; -.
DR   BioMuta; PEF1; -.
DR   DMDM; 74761895; -.
DR   REPRODUCTION-2DPAGE; IPI00018235; -.
DR   EPD; Q9UBV8; -.
DR   MaxQB; Q9UBV8; -.
DR   PaxDb; Q9UBV8; -.
DR   PeptideAtlas; Q9UBV8; -.
DR   PRIDE; Q9UBV8; -.
DR   DNASU; 553115; -.
DR   Ensembl; ENST00000373703; ENSP00000362807; ENSG00000162517.
DR   GeneID; 553115; -.
DR   KEGG; hsa:553115; -.
DR   UCSC; uc001bth.3; human.
DR   CTD; 553115; -.
DR   GeneCards; PEF1; -.
DR   HGNC; HGNC:30009; PEF1.
DR   HPA; HPA061608; -.
DR   MIM; 610033; gene.
DR   neXtProt; NX_Q9UBV8; -.
DR   OpenTargets; ENSG00000162517; -.
DR   PharmGKB; PA142671184; -.
DR   eggNOG; KOG0037; Eukaryota.
DR   eggNOG; ENOG410YKQK; LUCA.
DR   GeneTree; ENSGT00620000087734; -.
DR   HOGENOM; HOG000231983; -.
DR   HOVERGEN; HBG004492; -.
DR   InParanoid; Q9UBV8; -.
DR   OMA; PSMQLDR; -.
DR   OrthoDB; EOG091G0ISY; -.
DR   PhylomeDB; Q9UBV8; -.
DR   TreeFam; TF314682; -.
DR   GeneWiki; PEF1; -.
DR   GenomeRNAi; 553115; -.
DR   PRO; PR:Q9UBV8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162517; -.
DR   CleanEx; HS_PEF1; -.
DR   Genevisible; Q9UBV8; HS.
DR   GO; GO:0030127; C:COPII vesicle coat; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0060090; F:binding, bridging; IMP:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; TAS:ProtInc.
DR   GO; GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0048208; P:COPII vesicle coating; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0014032; P:neural crest cell development; IMP:UniProtKB.
DR   GO; GO:0014029; P:neural crest formation; IMP:UniProtKB.
DR   GO; GO:1902527; P:positive regulation of protein monoubiquitination; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IBA:GO_Central.
DR   GO; GO:0051592; P:response to calcium ion; IPI:UniProtKB.
DR   CDD; cd00051; EFh; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF13405; EF-hand_6; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 3.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Isopeptide bond; Membrane; Metal-binding;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    284       Peflin.
FT                                /FTId=PRO_0000247045.
FT   REPEAT       21     29       1. {ECO:0000305}.
FT   REPEAT       31     39       2. {ECO:0000305}.
FT   REPEAT       41     49       3. {ECO:0000305}.
FT   REPEAT       50     58       4. {ECO:0000305}.
FT   REPEAT       59     67       5. {ECO:0000305}.
FT   REPEAT       76     84       6. {ECO:0000305}.
FT   REPEAT       85     92       7. {ECO:0000305}.
FT   REPEAT       93    100       8. {ECO:0000305}.
FT   REPEAT      101    109       9. {ECO:0000305}.
FT   DOMAIN      114    149       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      155    183       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      181    216       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      217    253       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      254    283       EF-hand 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     127    138       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     194    205       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION       21    109       9 X 9 AA approximate tandem repeat of
FT                                [AP]-P-G-G-P-Y-G-G-P-P. {ECO:0000305}.
FT   REGION      204    284       Required for interaction with PDCD6.
FT                                {ECO:0000269|PubMed:11883899}.
FT   CROSSLNK    137    137       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:27716508}.
FT   MUTAGEN     137    137       K->R: Decreased ubiquitination by the
FT                                BCR(KLHL12) E3 ubiquitin ligase complex.
FT                                {ECO:0000269|PubMed:27716508}.
FT   MUTAGEN     165    165       K->R: Does not affect ubiquitination by
FT                                the BCR(KLHL12) E3 ubiquitin ligase
FT                                complex. {ECO:0000269|PubMed:27716508}.
FT   MUTAGEN     167    167       K->R: Does not affect ubiquitination by
FT                                the BCR(KLHL12) E3 ubiquitin ligase
FT                                complex. {ECO:0000269|PubMed:27716508}.
CC   --------------------------------------------------------------------------
CC   The following FT lines are automated annotations from the MyHits database.
CC   --------------------------------------------------------------------------
FT   MYHIT       118    146       ismart:EFh [T]
FT   MYHIT       186    212       ipfam:EF-hand_6 [T]
FT   MYHIT       194    206       ipat:EF_HAND_1 [T]
FT   MYHIT       127    139       ipat:EF_HAND_1 [T]
FT   MYHIT       181    216       iprf:EF_HAND_2 [T]
FT   MYHIT       185    213       ismart:EFh [T]
FT   MYHIT       155    183       ismart:EFh [T]
FT   MYHIT       120    179       ipfam:EF-hand_7 [T]
FT   MYHIT       114    149       iprf:EF_HAND_2 [T]
SQ   SEQUENCE   284 AA;  30381 MW;  2E9AA5750CB7A68A CRC64;
     MASYPYRQGC PGAAGQAPGA PPGSYYPGPP NSGGQYGSGL PPGGGYGGPA PGGPYGPPAG
     GGPYGHPNPG MFPSGTPGGP YGGAAPGGPY GQPPPSSYGA QQPGLYGQGG APPNVDPEAY
     SWFQSVDSDH SGYISMKELK QALVNCNWSS FNDETCLMMI NMFDKTKSGR IDVYGFSALW
     KFIQQWKNLF QQYDRDRSGS ISYTELQQAL SQMGYNLSPQ FTQLLVSRYC PRSANPAMQL
     DRFIQVCTQL QVLTEAFREK DTAVQGNIRL SFEDFVTMTA SRML
//